China’s Biotech Future

China's Biotech Future

Continuing our interview series with life sciences venture capitalists to accompany a study on venture capital in emerging markets published in the March 7th, 2013, issue of Nature Biotechnology, we return to China. Our third interview is with a venture capitalist, who wishes to remain anonymous, from the one of the most prolific early-stage life sciences investors in China (14 innovation-focused investments to date). Previous posts are here and here.  Read more

Insights from India

Insights from India

Continuing our interview series with life sciences venture capitalists (here for previous post) to accompany a study on venture capital in emerging markets published in the March 7th, 2013, issue of Nature Biotechnology, we turn our eye to India. Our second interview is with Aditya Kapil, who was a principal at VentureEast at the time of our interview in 2012.  Read more

Life Science Venture Capital in Emerging Markets: a View on China

Life Science Venture Capital in Emerging Markets: a View on China

As part of a study on venture capital in emerging markets published in the March 7th, 2013, issue of Nature Biotechnology, my colleagues and I interviewed several life sciences venture capitalists operating in emerging markets. In the coming weeks, we will be sharing some of the insights from these investors here on Trade Secrets.  Read more